Structure-activity relationships: from tubocurarine to the present day

Agoston, 1980, The neuromuscular blocking action of Org NC45, a new pancuronium derivative, in anaesthetised patients: a pilot study, British Journal of Anaesthesia, 52, 53S, 10.1093/bja/52.suppl_1.53S Baird, 1967, The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man, British Journal of Anaesthesia, 39, 775, 10.1093/bja/39.10.775 Bamford, 1971, The neuromuscular blocking activity of some monoquaternary androstane derivatives, Journal of Pharmacology and Chemotherapeutics, 23, 595, 10.1111/j.2042-7158.1971.tb08723.x Bamford, 1972, A novel monoquaternary neuromuscular blocking agent, Experientia, 28, 1069, 10.1007/BF01918678 Barlow, 1948, Curare-like action of bis-quaternary ammonium salts, Nature, 161, 718, 10.1038/161718a0 Barlow, 1964, Some effects of long chain polymethylene-bis-onium salts on junctional transmission in the peripheral system, British Journal of Pharmacology, 123, 131 Barnes, 1986, Plasma histamine levels following atracurium, Anaesthesia, 41, 821, 10.1111/j.1365-2044.1986.tb13124.x Basta, 1982, Clinical pharmacology of atracurium besylate (BW33A): a new non-depolarizing muscle relaxant, Anesthesia and Analgesia, 61, 723, 10.1213/00000539-198209000-00002 Basta, 1983, Histamine releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine, British Journal of Anaesthesia, 55, 105S Basta, 1988, Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant, Anesthesiology, 69, 478, 10.1097/00000542-198810000-00006 Biró, 1986, Bisquaternary steroid derivatives, vol. 79, 401 Blogg, 1973, A new muscle relaxant—AH 8165, 66, 1023 Booij, 1991, The neuromuscular blocking effect of Org 9426, Anaesthesia, 46, 341, 10.1111/j.1365-2044.1991.tb09539.x Bovet, 1951, Some aspects of the relationship between chemical constitution and curare-like activity, Annals of the New York Academy of Science, 54, 407, 10.1111/j.1749-6632.1951.tb39934.x Bovet, 1972, Synthetic inhibitors of neuromuscular transmission, chemical structures and structure activity relationships, 243 Bovet, 1959 Bowman, 1988, Structure: action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anaesthetised cat, Anesthesiology, 69, 57, 10.1097/00000542-198807000-00009 Buckett, 1968, The pharmacology of pancuronium bromide (Org NA97) a new potent steroidal neuromuscular blocking agent, British Journal of Pharmacology and Chemotherapeutics, 32, 671, 10.1111/j.1476-5381.1968.tb00466.x Busfield, 1968, Neuromuscular blocking activities of some steroidal mono- and bis-quaternary ammonium compounds with special reference to NN′-dimethylconessine, Journal of Pharmacology and Chemotherapeutics, 33, 609, 10.1111/j.1476-5381.1968.tb00461.x Cavallito, 1959, Some interrelationships of chemical structure, physical properties and curarimimetic action, 288 Cavallito, 1962, Structure-action relationships throwing light on the receptor, 55 Cavallito, 1968, Some relationship of chemical structure and pharmacological activities, Annual Review of Pharmacology, 8, 39, 10.1146/annurev.pa.08.040168.000351 Collier, 1952, The effect of chain-length on curarizing potency in three homologous series, British Journal of Pharmacology, 7, 392 Collier, 1958, Some new neuromuscular blocking agents, Nature, 182, 1424, 10.1038/1821424a0 Copp, 1972, Two new short-acting non-depolarizing neuromuscular blocking agents, Experientia, 28, 47, 10.1007/BF01928257 D'Arcy, 1962, Quaternary ammonium compounds in medicinal chemistry, I–II, Journal of Pharmacy and Pharmacology. (London), 14, 129, 10.1111/j.2042-7158.1962.tb11069.x D'Arcy, 1962, Quaternary ammonium compounds in medicinal chemistry, I–II, Journal of Pharmacy and Pharmacology. (London), 14, 193, 10.1111/j.2042-7158.1962.tb11081.x Davis, 1991, Evaluation of histamine release following ORG 9426 administration using a new radioimmunoassay, Anesthesiology, 75, A818, 10.1097/00000542-199109001-00817 Donati, 1993, Effect of dose and potency on onset, Anaesthetic Pharmacology Review, 1, 34 Donati, 1991, A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs, Journal of Pharmacokinetics and Biopharmaceutics, 19, 537, 10.1007/BF01062962 Duncalf, 1981, Relaxation with Org-NC45 during enflurane anesthesia, Anesthesiology, 55, A203 Durant, 1979, The neuromuscular and autonomic blocking activities of pancuronium, Org NC45, and other pancuronium analogues, in the cat, Journal of Pharmacy and Pharmacology, 31, 831, 10.1111/j.2042-7158.1979.tb13675.x Everett, 1970, Revision of the structures of (+)-tubocurarine chloride and (+)-chondocurine, Journal of the Chemical Society, D, 1020 Fahey, 1981, Clinical Pharmacology of Org NC45 (Norcuron™): a new nondepolarizing muscle relaxant, Anesthesiology, 55, 6, 10.1097/00000542-198107000-00003 Foldes, 1990, Neuromuscular and cardiovascular effects of pipecuronium, Canadian Journal of Anaesthesia, 37, 549, 10.1007/BF03006324 Foldes, 1991, The neuromuscular effects of ORG 9426 in patients receiving balanced anesthesia, Anesthesiology, 75, 191, 10.1097/00000542-199108000-00004 Fusco, 1951, Qualche consideraziones sul tema: struttura chimica et attività dei curari di sintesi, Rendiconti: Instituto Superiore di Sanità, 14, 690 Griffith, 1942, The use of curare in general anesthesia, Anesthesiology, 3, 418, 10.1097/00000542-194207000-00006 Haining, 1960, The neuromuscular blocking properties of a series of bis-quaternary tropeins, British Journal of Pharmacology and Chemotherapy, 15, 71, 10.1111/j.1476-5381.1960.tb01212.x Healy, 1986, Atracurium and vecuronium: Effect of dose on the time of onset, British Journal of Anaesthesia, 58, 620, 10.1093/bja/58.6.620 Hoppe, 1951, A new series of synthetic curare-like compounds, Annals of the New York Academy of Science, 54, 395, 10.1111/j.1749-6632.1951.tb39933.x Hughes, 1972, Evaluation of the neuromuscular blocking properties and side-effects of the two new isoquinolinium bisquaternary compounds (BW.252C64 and BW.403C65), British Journal of Anaesthesia, 44, 27, 10.1093/bja/44.1.27 Hughes, 1976, Studies on fazadinium bromide (AH 8165): a new non-depolarizing neuromuscular blocking agent, Canadian Anaesthetic Society Journal, 23, 36, 10.1007/BF03004993 Hunter, 1982, Use of atracurium during general surgery monitored by the train-of-four stimuli, British Journal of Anaesthesia, 54, 1243, 10.1093/bja/54.12.1243 Huu-Lainé, 1964, Activité curarisante du dichlorure de 3β-20α bistrimethylammonium 5α-prégnane (malouétine) et de ses stéréoisomères, Archives Internationales de Pharmacodynamie et de Thérapie, 147, 209 Ing, 1936, The curariform action of onium salts, Physiological Reviews, 16, 527, 10.1152/physrev.1936.16.4.527 1986, vol. 79 Iharkevich, 1986, The derivatives of carboxylic acids, vol. 79, 323 King, 1935, Curare alkaloids. Part 1. Tubocurarine, Journal of the Chemical Society, 2, 1381, 10.1039/jr9350001381 Maehr, 1991, Autonomic and neuromuscular effects of mivacurium and isomers in cat, Anesthesiology, 75, A772, 10.1097/00000542-199109001-00771 Marshall, 1973, Steroids and related studies. 22. Some actions of 4,17-dimethyl-4,17-diaza-D-homo-5-α-androstane dimethiodide (HS-342), a new neuromuscular blocking drug, Journal of Pharmacology and Chemotherapeutics, 25, 441, 10.1111/j.2042-7158.1973.tb09130.x Martin-Smith, 1972, Rational elements in the development of superior neuromuscular blocking agents, vol. 2, 453 Miller, 1986, Vecuronium (ORG NC-45), vol. 79, 617 Morris, 1983, The cardiovascular effects of vecuronium (ORG NC45) and pancuronium in patients undergoing coronary artery bypass grafting, Anesthesiology, 58, 438, 10.1097/00000542-198305000-00008 Mushin, 1964, Relaxant action in man of dipyrandium chloride (M&B 9105A) (A steroid bis-quaternary ammonium salt), British Journal of Anaesthesia, 36, 761, 10.1093/bja/36.12.761 Nomenclature Committee, 1991, Nomenclature for muscarinic receptor subtypes recommended by the IV symposium on subtypes of muscarinic receptors, July 1989, Trends in Pharmacologic Science. Receptor Nomenclature Supplement, January 1991, 12, 19 Paton, 1962, Neuromuscular blocking agents, British Journal of Anaesthesia, 34, 251, 10.1093/bja/34.4.251 Paton, 1948, Curare-like action of polymethylene bis-quaternary ammonium salts, Nature, 161, 718, 10.1038/161718b0 Paton, 1949, The pharmacological actions of polymethylene bistrimethylene bistrimethylammonium salts, British Journal of Pharmacology, 4, 381 Payne, 1981, Evaluation of atracurium in anaesthetised man, British Journal of Anaesthesia, 53, 45, 10.1093/bja/53.1.45 Riesz, 1986, Steroid derivatives, vol. 79, 301 Sastry, 1993, Nicotinic receptor, Anaesthetic Pharmacology Review, 1, 6 Savarese, 1988, The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U), Anesthesiology, 68, 723, 10.1097/00000542-198805000-00010 Savarese, 1989, The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia, Anesthesiology, 70, 386, 10.1097/00000542-198903000-00003 Savarese, 1973, The quest for a short-acting nondepolarizing neuromuscular blocking agent, Acta Anaesthesiologica Scandinavica, 53, 45 Savege, 1973, The cardiovascular effects of AH 8165. A new non-depolarizing muscle relaxant, Anaesthesia, 28, 253, 10.1111/j.1365-2044.1973.tb00444.x Scott, 1985, Atracurium: Clinical strategies for preventing histamine release and attenuating the haemodynamic response, British Journal of Anaesthesia, 57, 550, 10.1093/bja/57.6.550 Simpson, 1972, An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarizing muscle relaxant, Lancet, i, 516, 10.1016/S0140-6736(72)90178-X Stenlake, 1981, Neuromuscular blocking agents, 431 Thesleff, 1954, Differences in mode of neuromuscular blockade in a series of symmetrical bis-quaternary ammonium salts, Journal of Pharmacology and Experimental Therapeutics, 111, 99 Torf, 1952, Zavisimost mezhdy farmakologicheskimi svoistvami u khimicheskim stroeniem v ryadu difeniletana, Farmakologiya i Toksikologiya, 15, 12 Tyres, 1986, Fazadinium dibromide, vol. 79, 629 van den Broek, 1991, Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent, Anesthesia and Analgesia, 72, 811 van Rossum, 1959, Pharmacodynamics of drugs affecting skeletal muscle. Structure-action relationship in homologous series of quaternary ammonium salts, Archives Internationales de Pharmacodynamie et de Thérapie, 118, 393 Waser, 1972, Chemistry and pharmacology of natural curare compounds, 205 Wierda, 1990, Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal non-depolarizing agent, British Journal of Anaesthesia, 64, 521, 10.1093/bja/64.4.521 Wintersteiner, 1943, Curare alkaloids from Chondodendron tomentosum, Science, 97, 467, 10.1126/science.97.2525.467 Zaimis, 1950, The synthesis of methonium compounds, their isolation from urine, and their photometric determination, British Journal of Pharmacology, 5, 424